|
Market Closed -
Nasdaq
23:00:00 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 11.46 USD | -4.42% |
|
+5.52% | +17.90% |
| 10-01 | Replimune Receives Approval to Launch Tudriqev in the US for Melanoma | MT |
| 10-01 | Replimune Group, Inc. Announces Tudriqev? Now Commercially Available in the United States for Advanced Melanoma | CI |
| Market Cap | 1.08B 964M 891M 807M 1.51B 103B 1.54B 10.72B 4.24B 53.7B 4.05B 3.97B 169B | P/E 2027 * |
-3.72x | P/E 2028 * | -5.38x |
|---|---|---|---|---|---|
| Enterprise Value | 979M 875M 808M 732M 1.37B 92.96B 1.39B 9.72B 3.85B 48.71B 3.68B 3.6B 154B | EV / Sales 2027 * |
33.9x | EV / Sales 2028 * | 6x |
| Free-Float |
98.35% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REPL | Delayed | |
CBOE
| REPL | Real-time | |
|
Deutsche Boerse AG
| 7R8 | Delayed | |
|
Börse Stuttgart
| 7R8 | Delayed | |
|
Boerse Muenchen
| 7R8 | Real-time | |
|
Tradegate
| 7R8 | Real-time |
Last Transcript: Replimune Group, Inc.
| 1 day | -4.42% | ||
| 1 week | +5.52% | ||
| Current month | -13.44% | ||
| 1 month | -9.05% | ||
| 3 months | +18.14% | ||
| 6 months | +373.55% | ||
| Current year | +17.90% |
| 1 week | 10.67 |  | 12.04 |
| 1 month | 10.67 | | 13.83 |
| Current year | 1.5 | | 16.33 |
| 1 year | 1.5 | | 16.33 |
| 3 years | 1.5 | | 17 |
| 5 years | 1.5 | | 35.93 |
| 10 years | 1.5 | | 54.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sushil Patel
CEO | Chief Executive Officer | 55 | 01/04/2024 |
Emily Hill
DFI | Director of Finance/CFO | 46 | 19/09/2023 |
| Chief Tech/Sci/R&D Officer | 60 | 01/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 54 | 01/04/2024 | |
Kapil Dhingra
BRD | Director/Board Member | 66 | 01/07/2017 |
Dieter Weinand
CHM | Chairman | 65 | 01/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/20/26 A | Don | Founder | -50,000 | 0.0641% | ||
| 8/17/26 A | Sell | Chief Financial Officer | -9,256 | 0.0119% | ||
| 8/11/26 A | Baker Bros. Advisors LP
| Buy | Company | 2,736,340 | 3.5056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.42% | +5.52% | +30.23% | -17.61% | 1.08B | |
| +2.41% | +0.29% | +39.41% | +72.14% | 64.69B | |
| -0.15% | +7.50% | +11.42% | +71.27% | 54.78B | |
| +0.57% | +4.60% | +7.71% | +90.93% | 53.49B | |
| +0.37% | +4.67% | +26.68% | +49.64% | 45.98B | |
| -1.21% | +2.32% | +21.50% | +118.33% | 42.94B | |
| -0.37% | +5.07% | +243.23% | +789.58% | 40.08B | |
| +0.05% | +0.21% | +18.06% | +48.50% | 33.52B | |
| +1.19% | -4.98% | +26.31% | -0.76% | 23.97B | |
| -0.38% | +5.68% | +38.39% | +28.35% | 23.67B | |
| Average | -0.19% | +2.72% | +46.29% | +125.04% | 38.42B | |
| Weighted average by Cap. | +0.38% | +2.74% | +45.97% | +142.39% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 28.87M 25.78M 23.81M 21.58M 40.38M 2.74B 41.04M 287M 113M 1.44B 108M 106M 4.53B | 173M 154M 142M 129M 241M 16.38B 245M 1.71B 678M 8.58B 648M 634M 27.06B |
| Net income | -306M -273M -252M -229M -428M -29.03B -435M -3.04B -1.2B -15.21B -1.15B -1.12B -47.95B | -229M -204M -189M -171M -320M -21.7B -325M -2.27B -898M -11.37B -858M -840M -35.84B |
| Net Debt | -100M -89.7M -82.87M -75.1M -140M -9.54B -143M -997M -395M -5B -377M -369M -15.75B | -44.05M -39.34M -36.34M -32.93M -61.62M -4.18B -62.64M -437M -173M -2.19B -165M -162M -6.91B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/10/26 | $11.46 | -4.42% | 1,905,060 |
| 22/10/26 | $11.99 | +2.30% | 1,760,788 |
| 21/10/26 | $11.72 | +2.63% | 2,202,154 |
| 20/10/26 | $11.42 | +3.35% | 1,388,933 |
| 19/10/26 | $11.05 | +1.75% | 1,539,679 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REPL Stock
Select your edition
All financial news and data tailored to specific country editions
